Inventor

SAHIN UGUR

DE206 patents

⚠️ This page may combine multiple inventors who share the name “SAHIN UGUR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAHIN UGUR

SAHIN UGUR

Monoclonal antibodies against claudin-18 for treatment of cancer

Monoclonal antibodies for treatment of cancer

Antigen-specific T cell receptors and T cell epitopes

Modification of RNA, producing an increased transcript stability and translation efficiency

Genetic products differentially expressed in tumors and the use thereof

Antibodies specific for claudin 6 (CLDN6)

Genetic products differentially expressed in tumors and the use thereof

Monoclonal antibodies against claudin-18 for treatment of cancer

Genetic products differentially expressed in tumors and the use of thereof

Cancer therapy using CLDN6 target-directed antibodies in vivo

Antibodies for treatment of cancer

Monoclonal antibodies against claudin-18 for treatment of cancer

Individualized vaccines for cancer

Identification of tumor-associated markers for diagnosing or monitoring ovarian cancer

Identification of tumor-associated antigens for diagnosis and therapy

Antigen-specific T cell receptors and T cell epitopes

Monoclonal antibodies against claudin-18 for treatment of cancer

Vaccine composition comprising 5′-cap modified RNA

GANYMED PHARMACEUTICALS AG

Genetic products differentially expressed in tumors and the use thereof

Monoclonal antibodies against claudin-18 for treatment of cancer

Identification of surface-associated antigens for tumor diagnosis and therapy

Therapy involving antibodies against Claudin 18.2 for treatment of cancer

Antibodies for treatment of cancer expressing claudin 6

Monoclonal antibodies against claudin-18 for treatment of cancer

Antibodies against claudin 18.2 useful in cancer diagnosis

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma

Antibodies against Claudin 18.2 useful in cancer diagnosis

LUDWIG INST CANCER RES

Isolated peptides consisting of amino acid sequences found in SSX or NY-ESO-1 molecules, which bind to HLA molecules

Isolated peptides which bind to MHC class II molecules, and uses thereof

Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof

Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith

Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells

Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith

BIONTECH AG

Modification of RNA, producing an increased transcript stability and translation efficiency

Identification of surface-associated antigens for tumor diagnosis and therapy

Identification of tumor-associated cell surface antigens for diagnosis and therapy

Identification of surface-associated antigens for tumor diagnosis and therapy

BIONTECH RNA PHARMACEUTICALS GMBH

Particles comprising a shell with RNA

Stabilization of poly(A) sequence encoding DNA sequences

RNA formulation for immunotherapy

Method for reducing immunogenicity of RNA

GENMAB AS

Multispecific antibodies against CD40 and CD137

Methods of producing multispecific antibodies against CD40 and CD137

Multispecific antibodies against CD40 and CD137

CORNELL RES FOUNDATION INC

Isolated nucleic acid molecule encoding an esophageal cancer associated antigen, the antigen itself, and uses thereof

BioNTech SE

Coronavirus vaccine

Türeci Özlem

Genetic products differentially expressed in tumors and the use thereof

TUERECI OEZLEM

Recombinant vaccines and use thereof

GANYMED PHARMACEUTICALS GMBH

Monoclonal antibodies against claudin-18 for treatment of cancer